Skip Navigation


Rheumatology Advance Access originally published online on February 17, 2004
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
43/5/583    most recent
keh116v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (12)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Goodacre, L. J.
Right arrow Articles by Goodacre, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goodacre, L. J.
Right arrow Articles by Goodacre, J. A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology 2004; 43: 583-586
Rheumatology Vol. 43 No. 5 (c) British Society for Rheumatology 2004; all rights reserved

Clinical

Factors influencing the beliefs of patients with rheumatoid arthritis regarding disease-modifying medication

L. J. Goodacre and J. A. Goodacre

Chronic Disease and Rehabilitation Interdisciplinary Research and Teaching Group, Lancashire School of Health and Postgraduate Medicine, University of Central Lancashire, Preston, UK.

Correspondence to: L. Goodacre, Lancashire Postgraduate School of Medicine and Health, University of Central Lancashire, Preston, Lancs PR1 2HE, UK. E-mail: lgoodacre{at}uclan.ac.uk

Objective. To investigate factors influencing the beliefs of patients with rheumatoid arthritis (RA) regarding disease-modifying medication.

Method. Twenty-nine patients with RA either starting a disease-modifying anti-rheumatic drug (DMARD) for the first time or changing DMARD were recruited. Semi-structured interviews, activity diaries and focus groups were conducted over 9 months. A coding framework was developed and data analysed using the constant comparative method to identify key themes.

Results. DMARDs were perceived as central to the management of RA but strong concerns were expressed about potential long-term effects. Beliefs about DMARDs were informed by material from a wide range of sources. Judgements of efficacy were influenced by symptom relief, occurrence of side-effects and perception of alternative treatment options. Perception, reporting and tolerance of side-effects differed widely between individuals. The emotional impact of starting and being withdrawn from medication appeared stronger in people with more experience of DMARD use.

Conclusions. Patients have complex and evolving belief systems relating to DMARDs. Understanding these systems will facilitate the provision of appropriate information and effective support not only in decision-making about treatment but also in relation to discontinuing treatment.

KEY WORDS: Beliefs, Decision-making, Medication, Rheumatoid arthritis.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Rheumatology (Oxford)Home page
S. A. Chambers, R. Raine, A. Rahman, and D. Isenberg
Why do patients with systemic lupus erythematosus take or fail to take their prescribed medications? A qualitative study in a UK cohort
Rheumatology, March 1, 2009; 48(3): 266 - 271.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
L. Goodacre, J. Smith, D. Meddis, and J. Goodacre
Development and validation of a patient-centred Measure of Activity Limitation (MAL) in rheumatoid arthritis
Rheumatology, April 1, 2007; 46(4): 703 - 708.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
G. J. Treharne, A. C. Lyons, E. D. Hale, K. M. J. Douglas, and G. D. Kitas
Re: Drug survival in rheumatoid arthritis--an interesting method but not a measure of adherence or concordance
Rheumatology, September 1, 2006; 45(9): 1178 - 1179.
[Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
G. J. Treharne, A. C. Lyons, E. D. Hale, K. M. J. Douglas, and G. D. Kitas
'Compliance' is futile but is 'concordance' between rheumatology patients and health professionals attainable?
Rheumatology, January 1, 2006; 45(1): 1 - 5.
[Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
G. J. Treharne, A. C. Lyons, E. D. Hale, K. M. J. Douglas, and G. D. Kitas
Predictors of medication adherence in people with rheumatoid arthritis: studies are necessary but non-validated measures of medication adherence are of concern
Rheumatology, October 1, 2005; 44(10): 1330 - 1330.
[Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
R. Neame and A. Hammond
Beliefs about medications: a questionnaire survey of people with rheumatoid arthritis
Rheumatology, June 1, 2005; 44(6): 762 - 767.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
W. Holden, J. Joseph, and L. Williamson
Re: Goodacre and Goodacre. Factors influencing the beliefs of patients with rheumatoid arthritis regarding disease-modifying medication
Rheumatology, December 1, 2004; 43(12): 1594 - 1594.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.